Antagonists for the imaging of GRPR-expressing PCa, such as RM2 for PET ([68Ga]Ga-RM2) and single-photon emission computed tomography (SPECT) ([111In]In-RM2), have shown promising preclinical results. The gene discussed is GRPR; the disease is posterior cortical atrophy.